Summary by Futu AI
Ming Kand Pharmaceuticals (stock code: 2359) announced an adjustment to the cash dividend per share distribution under the 2023 profit distribution plan. THE COMPANY ORIGINALLY PLANNED TO DISTRIBUTE CASH DIVIDENDS OF RMB9.8336 PER 10 SHARES PER 10 SHARES, AS PROPOSED IN ITS ANNUAL RESULTS ANNOUNCEMENT ON 18 MARCH 2024 AND THE DISTRIBUTION PLAN PROPOSED IN THE CIRCULAR DATED 10 MAY 2024. As the Company repurchased shares from March 18 to May 22, 2024 and cancelled 41,869,187 shares of Class A shares, as well as inducement vesting and completing the share transfer registration of 316,551 shares A shares, resulting in a decrease in the total share capital entitled to profit distribution. Therefore, according to the principle of keeping the total profit distribution unchanged, the company's adjusted cash dividend per 10 shares was RMB9,8974, totaling RMB2,882,050,829.90. The adjustment plan is subject to approval at the Annual General Meeting on June 12, 2024.